KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation

PURPOSE: Disease relapse remains a major challenge to successful outcomes in patients who undergo allogeneic hematopoietic cell transplantation (HCT). Donor natural killer (NK) cell alloreactivity in HCT can control leukemic relapse, but capturing alloreactivity in HLA-matched HCT has been elusive....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Boudreau, Jeanette E., Giglio, Fabio, Gooley, Ted A., Stevenson, Philip A., Le Luduec, Jean-Benoît, Shaffer, Brian C., Rajalingam, Raja, Hou, Lihua, Hurley, Carolyn Katovich, Noreen, Harriet, Reed, Elaine F., Yu, Neng, Vierra-Green, Cynthia, Haagenson, Michael, Malkki, Mari, Petersdorf, Effie W., Spellman, Stephen, Hsu, Katharine C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501362/
https://ncbi.nlm.nih.gov/pubmed/28520526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.7059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados